Please login to the form below

Not currently logged in
Email:
Password:

AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance

He joins the biopharma from Tang Capital Management

AVEO Oncology has appointed Dr Nikhil Mehta as senior vice president or regulatory and quality assurance, a role that will see him oversee all aspects of regulatory, quality and technical operations for the company’s portfolio.

Dr Mehta brings over 25 years’ experience in biotechnology and pharmaceutical industries to AVEO and most recently, Dr Mehta served as executive vice president and chief regulatory strategies at Tang Capital Management, where he was involved in establishing two biopharmaceutical companies.

Prior to Tang Capital, he served as global head of regulatory affairs at Baxalta and before that, he was vice president, global regulatory affairs, oncology, haematology, immunology and diagnostics at Merck & Co.

He has also held roles for Shire, Bristol-Myers Squibb and Hoffman-La Roche.

Michael Baily, president and chief executive officer, AVEO, said: “Dr Mehta brings to AVEO a depth of experience in regulatory affairs and oncology that we believe will be invaluable as we plan and advance our US registration strategy for tivozanib as a potential treatment for renal cell carcinoma.”

“I anticipate Dr Mehta’s integration into the AVEO team will be seamless and rapidly productive and we look forward to working with him.”

11th December 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics